Redhill Biopharma (RDHL) Institutional Ownership $1.34 -0.02 (-1.11%) As of 10:26 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Redhill Biopharma (NASDAQ:RDHL)CurrentInstitutional OwnershipPercentage7.20%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$31.60KNumber ofInstitutional Sellers(last 12 months)0 Get RDHL Insider Trade Alerts Want to know when executives and insiders are buying or selling Redhill Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data RDHL Institutional Buying and Selling by Quarter Redhill Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/3/2025 GAMMA Investing LLC5,089$32K0.0%N/A0.397% 5/14/2024 Gagnon Securities LLC118,360$63K0.0%+32.1%0.398% 11/15/2023 Sabby Management LLC635,006$324K0.2%N/A5.736% 11/15/2023 Armistice Capital LLC722,894$369K0.0%N/A6.530% 8/7/2023Cowen AND Company LLC288,000$346K0.0%N/A7.328% 2/7/2023 Gagnon Securities LLC331,858$47K0.0%-14.0%0.518% 2/7/2023 CLARET ASSET MANAGEMENT Corp228,430$32K0.0%+139.4%0.357% 11/7/2022 Virtu Financial LLC62,182$31K0.0%+44.8%0.118% 7/11/2022 ARK Investment Management LLC1,045,023$1.17M0.0%+21.3%1.984% 5/16/2022 Disciplined Growth Investors Inc. MN1,950,002$4.91M0.1%+0.7%3.701% Get the Latest News and Ratings for RDHL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Redhill Biopharma and its competitors with MarketBeat's FREE daily newsletter. 5/9/2022 Gagnon Securities LLC367,346$926K0.2%+15.4%0.697% 4/19/2022 ARK Investment Management LLC861,798$2.17M0.0%N/A1.636% 2/15/2022 Disciplined Growth Investors Inc. MN1,935,589$4.99M0.1%-2.1%3.694% 2/14/2022 GSA Capital Partners LLP218,338$563K0.1%+108.4%0.417% 2/10/2022 Candriam Luxembourg S.C.A.71,267$184K0.0%-13.6%0.136% 2/10/2022 HighTower Advisors LLC12,300$32K0.0%N/A0.023% 2/8/2022 Gagnon Securities LLC318,323$821K0.1%-18.8%0.607% 2/7/2022 Ibex Investors LLC261,616$675K0.2%-63.4%0.499% 2/7/2022 CLARET ASSET MANAGEMENT Corp95,430$246K0.0%+52.1%0.182% 2/3/2022 Cambridge Investment Research Advisors Inc.27,632$71K0.0%N/A0.053% 1/24/2022 National Bank of Canada FI43,000$111K0.0%N/A0.082% 12/2/2021 CLARET ASSET MANAGEMENT Corp62,730$287K0.0%+14.1%0.120% 11/15/2021 Ancora Advisors LLC37,500$172K0.0%N/A0.080% 11/15/2021Eaton Vance Management38,417$176K0.0%N/A0.082% 11/15/2021 GSA Capital Partners LLP104,754$480K0.0%+28.1%0.224% 11/12/2021 Gagnon Securities LLC392,245$1.80M0.3%+14.5%0.841% 11/10/2021 Goldman Sachs Group Inc.76,368$350K0.0%+36.6%0.164% 11/9/2021BlackRock Inc.312,139$1.43M0.0%+8.2%0.669% 11/5/2021 Ibex Investors LLC715,293$3.28M0.7%-26.3%1.533% 11/5/2021 Advisor Group Holdings Inc.24,101$110K0.0%+288.7%0.052% 11/5/2021 ARS Investment Partners LLC52,495$240K0.0%-41.9%0.112% 11/4/2021 Woodward Diversified Capital LLC17,089$78K0.0%-56.0%0.037% 10/29/2021 Commonwealth Equity Services LLC11,687$53K0.0%N/A0.025% 10/27/2021 Ingalls & Snyder LLC29,000$133K0.0%+52.6%0.062% 10/27/2021 Phoenix Holdings Ltd.16,578$75K0.0%N/A0.036% 10/19/2021 Henry James International Management Inc.75,078$344K0.1%+17.2%0.161% 10/14/2021 Capital Asset Advisory Services LLC28,888$132K0.0%N/A0.062% 9/3/2021Parametric Portfolio Associates LLC45,856$315K0.0%+6.5%0.098% 8/16/2021 Disciplined Growth Investors Inc. MN1,976,476$13.60M0.3%+8.1%4.260% 8/16/2021 State Street Corp109,594$754K0.0%+16.2%0.236% [No Brainer Gold Play]: “Show me a better investment.” (Ad)A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.Click here to get Garrett’s Top Four picks now.8/16/2021 Goldman Sachs Group Inc.55,915$385K0.0%-4.6%0.121% 8/13/2021 Renaissance Technologies LLC19,879$137K0.0%N/A0.043% 8/13/2021 Jump Financial LLC14,700$101K0.0%N/A0.032% 8/13/2021 Geode Capital Management LLC27,229$187K0.0%+10.3%0.059% 8/12/2021 CIBC World Markets Inc.11,075$76K0.0%N/A0.024% 8/11/2021BlackRock Inc.288,363$1.98M0.0%-18.9%0.622% 8/6/2021 ARS Investment Partners LLC90,333$621K0.1%+2.8%0.195% 8/5/2021 Ibex Investors LLC970,936$6.68M2.3%-56.2%2.093% 8/5/2021 GSA Capital Partners LLP81,778$563K0.1%+350.5%0.176% 8/4/2021 Creative Planning67,601$465K0.0%-91.6%0.146% (Data available from 1/1/2016 forward) RDHL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RDHL shares? During the previous two years, the following institutional investors and hedge funds held shares of Redhill Biopharma shares: Armistice Capital LLC ($369K), Sabby Management LLC ($324K), and Gagnon Securities LLC ($63K), GAMMA Investing LLC ($32K).Learn more on Redhill Biopharma's institutional investors. What percentage of Redhill Biopharma's stock is owned by institutional investors? 7.20% of Redhill Biopharma's stock is owned by institutional investors. Learn more on RDHL's institutional investor holdings. Which institutional investors have been buying Redhill Biopharma's stock? The following institutional investors have purchased Redhill Biopharma's stock in the last 24 months: Armistice Capital LLC ($722.89K), Sabby Management LLC ($635.01K), Gagnon Securities LLC ($28.77K), and GAMMA Investing LLC ($5.09K). How much institutional buying is happening at Redhill Biopharma? Institutional investors have bought a total of 5,089 shares in the last 24 months. This purchase volume represents approximately $31.60K in transactions. Related Companies Phio Pharmaceuticals Institutional Ownership Mustang Bio Institutional Ownership Ernexa Therapeutics Institutional Ownership BioCardia Institutional Ownership Matinas Biopharma Institutional Ownership Synaptogenix Institutional Ownership HOOKIPA Pharma Institutional Ownership IN8bio Institutional Ownership Talphera Institutional Ownership Sensei Biotherapeutics Institutional Ownership This page (NASDAQ:RDHL) was last updated on 9/2/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredHit Your Retirement “Freedom Number” (Without $1 Million)Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredHave You Seen This? Trump Schedules 'Stock Market Reset' For Sept. 30Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Redhill Biopharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Redhill Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
